These changes are partially reversed in the presence of the NOS inhibitor L-NAME, NOX inhibitor apocynin, or PEG-SOD and are fully reversed by the eNOS co-factor BH4, confirming NOS uncoupling as a key mediator in this model of CAVD. Here, NOS1 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.